Waycross Medicaid payments for non-oral drug administration reach $9,190 in 2024

In 2024, Medicaid providers billed $9,190 in Waycross for non-oral drug administration services, as detailed in the U.S. Department of Health and Human Services Medicaid Provider Spending database. This amount is an increase of 18.3% compared with 2023, when claims for these services totaled $7,767.

Medicaid, a public health insurance program managed by states and funded jointly by federal and state governments, covers low-income individuals and families, seniors, children and those with disabilities, making it a major component of the U.S. health care system.

Because taxpayer money funds Medicaid, fluctuations in local billing levels highlight how public health funding is distributed within a community.

The non-oral drug administration services category groups together Medicaid claims defined by specific care types, based on standard HCPCS and CPT code sets. Service categories are created by assigning each billing code to one group with consistent code prefixes and numerical ranges, allowing related claims to be tracked collectively and ensuring accurate rankings without double counting.

While Medicaid spending grew in several service categories, non-oral drug administration placed fifth in Waycross for total Medicaid payments reported in 2024.

Statewide in Georgia, the non-oral drug administration category was 13th among Medicaid service categories by total payments in 2024.

Looking at the five years prior to 2024, Medicaid payments tied to non-oral drug administration in Waycross rose by $9,094, representing a 9,476.9% increase. Some sharp jumps in spending occurred in 2021 and 2022.

Though spending for non-oral drug administration spanned the city, payments were highly localized in just a few ZIP codes. ZIP code 31501 alone accounted for $9,190 in Medicaid payments in 2024, comprising 100% of all payments under this category in Waycross for the year.

Payments for non-oral drug administration were also concentrated around a small set of billing codes within the category.

From 2023 to 2024, payments for non-oral drug administration in Waycross rose by 18.3%. By comparison, all Medicaid claim categories in the city saw a 22.4% change over the same timeframe.

According to the Centers for Medicare & Medicaid Services, Medicaid spending by federal and state governments totaled approximately $871.7 billion in fiscal year 2023—or about 18% of total national health expenditures. That’s a notable increase from $613.5 billion in 2019, before the onset of the COVID-19 pandemic.

The growth equates to about a 40% increase within a few years, fueled mainly by broader enrollment and rising use throughout and after the pandemic period.

Recent federal budget acts under the Trump administration have introduced measures to curtail Medicaid funding and revise the program. The “One Big Beautiful Bill Act,” enacted in 2025, is anticipated to reduce federal Medicaid expenditures by more than $1 trillion in the coming decade. This law also introduces changes—including work requirements and higher cost-sharing—that may decrease coverage and funding for some recipients. As a result, states are likely to take on more costs, and federal Medicaid growth may be restrained, even as millions continue to depend on the program.

Note: HCPCS codes are shown for context within the category. Category totals and rankings in this article are based on standardized service groupings rather than individual billing codes.

Information in this article was obtained from the U.S. Department of Health and Human Services Medicaid Provider Spending database. The source data can be found here.